Globus Medical director to sell 25,000 shares

GLOBUS MEDICAL INC (GMED) received a Rule 144 notice for a proposed sale of restricted or control securities.

Rhea-AI Filing Summary

GLOBUS MEDICAL INC (GMED) received a Rule 144 notice for a proposed sale of restricted or control securities. A director, Stephen T. Zarrilli, plans to sell 25,000 shares of common stock through Raymond James & Associates on the NYSE, with an indicated aggregate value of $2,176,000.00. The shares are to be issued via a cashless option exercise with the issuer as of 08/18/2026.

Key Figures

Shares to be sold: 25,000 shares Aggregate sale value: $2,176,000.00 Planned transaction date: 08/18/2026 +2 more

5 metrics

Shares to be sold 25,000 shares Common stock to be sold under Rule 144 for the account of Stephen T. Zarrilli

Aggregate sale value $2,176,000.00 Indicated aggregate value of 25,000 common shares to be sold

Planned transaction date 08/18/2026 Date associated with the cashless option exercise and planned sale

Security identifier 134261914 Identifier listed for the common stock in the securities information section

Exchange NYSE Planned venue for sale of the 25,000 common shares

Key Terms

Rule 144, cashless option exercise, cashless exercise, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

cashless option exercise financial

"Common | 08/18/2026 | Cashless Option Exercise | Issuer"

cashless exercise financial

"25000 | 08/18/2026 | Cashless Exercise"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

attorney-in-fact regulatory

"as attorney-in-fact for Stephen Zarrilli"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did GLOBUS MEDICAL INC (GMED) disclose in this Rule 144 filing?

The filing discloses a planned sale of 25,000 shares of Globus Medical common stock under Rule 144 by director Stephen T. Zarrilli, to be executed through Raymond James & Associates on the NYSE on 08/18/2026.

What is the total indicated value of the GMED shares to be sold under this Rule 144 notice?

The planned sale covers shares with an aggregate indicated value of $2,176,000.00. This amount is based on the figures provided for the 25,000 common shares to be sold through Raymond James & Associates on the NYSE.

Who is the insider selling GLOBUS MEDICAL INC (GMED) shares and in what capacity?

The selling person is Stephen T. Zarrilli, identified as a director of Globus Medical Inc. The Rule 144 notice specifies that the shares are being sold for his account, with attorney-in-fact authority granted to Raymond James & Associates’ representative.

What is the nature of the GMED shares being sold in this Rule 144 filing?

The shares are common stock of Globus Medical Inc., to be obtained via a cashless option exercise from the issuer and then sold. The filing describes the transaction as a “Cashless Option Exercise” and “Cashless Exercise” dated 08/18/2026.

Which broker is handling the planned Rule 144 sale of GMED shares?

The planned sale will be handled by Raymond James & Associates, Inc., located at 880 Carillon Parkway, St. Petersburg, FL 33716. The shares are expected to be sold on the NYSE as stated in the Rule 144 disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 04:24 PM Accepted by SEC EDGAR 08/18/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001203410
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GLOBUS MEDICAL INC
SEC File Number	001-35621
Address of Issuer	2560 GENERAL ARMISTEAD AVENUE AUDUBON PENNSYLVANIA 19403
Phone	610-930-1800
Name of Person for Whose Account the Securities are To Be Sold	ZARRILLI STEPHEN T
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates, Inc. 880 Carillon Parkway St. Petersburg FL 33716	25000	2176000.00	134261914	08/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/18/2026	Cashless Option Exercise	Issuer			25000	08/18/2026	Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Melissa Fisher, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Stephen Zarrilli
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)